New methods for detection of anti-nuclear antibodies

Clinical Immunology and Immunopathology

Volumn 88, Issue 3, 1998, Pages 211-220

  Cook, Linda ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA TOPOISOMERASE;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; COUNTER IMMUNOELECTROPHORESIS; DIAGNOSTIC VALUE; DOT HYBRIDIZATION; ENZYME IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; PRIORITY JOURNAL; REVIEW;

EID: 0032169094     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4560     Document Type: Review

References (70)

1. Hargraves M., Richmond H., Morton R. Presentation of two bone marrow components, the tart cell and the LE cell. Mayo Clin. Proc. 27:1948;25-28.
2. Kredich N. M., Skyler J. S., Foot L. J. Antibodies to native DNA in SLE: A technique of rapid quantitative determination. Arch. Intern. Med. 131:1973;639.
3. Mattioli M., Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Arthritis Rheum. 17:1974;421.
4. Alspaugh M. A., Tan E. M. Antibodies to cellular antigens in Sjogren's syndrome. J. Clin. Invest. 59:1977;254.
5. Sharp G. C., Irwin W., Tan E. M. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52:1972;148.
6. Sharp G. C., Irvin W. S., May C. M. Association of autoantibodies to ribonucleoprotein and SM antigens wit mixed connective tissue disease, systemic lupus erythematosis and other rheumatic diseases. N. Engl. J. Med. 295:1976;1149.
7. Douvas A. S., Achten M., Tan E. M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J. Biol. Chem. 254:1979;10514-10522.
8. Wolfe J. F., Adelstein E., Sharp G. C. Antinuclear antibody with distinct specificity for polymyositis. J. Clin. Invest. 59:1977;176-178.
9. Nishikai M., Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 23:1980;881-888.
10. Holborow E. J., Weir D. M., Johnson G. D. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br. Med. J. 2:1957;732.
11. Friou G. J. The early days of the antinuclear antibody story: Where and how did it all start. Ann. Med. Interne (Paris). 144:1993;154-156.
12. Kozen F., Fowler M., Koethe S. M. A comparison of the sensitivities and specificities of different substrates for the flourescent antinuclear antibody test. Am. J. Clin. Pathol. 74:1980;785-790.
13. Keech C. L., McClusky J., Gordon T. P. Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 Cells. Clin. Immunol. Immunopathol. 73:1994;146-151.
14. Fritzler M. J., Miller B. J. Detection of autoantibodes to SS-A/Ro by indirect immunofluorescence using a tranfected and overexpressed human 60 kD Ro autoantigen in Hep-2 cells. J. Clin. Lab. Anal. 9:1995;218-224.
15. Warlow R., Carrano J., Dawkins R. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens. Diag. Immunol. 2:1984;154-160.
16. Maddison P. J., Skinner R. P., Vlachoyiannopoulos P., Brennand D. M., Hough D. Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: Their specificity and interrelations in connective tissue disease. Clin. Exp. Immunol. 62:1985;337-345.
17. Merryman P., Louie P. Comparison of assay systems for detecting antibodies to nuclear ribonucleoproteins. J. Clin. Pathol. 44:1991;685-689.
18. James K., Meek G. Evaluation of commercial enzyme immunoassays compared to immunofluorescence and double diffusion for autoantibodies associated with autoimmune diseases. Am. J. Clin. Pathol. 97:1992;559-565.
19. Bon Durand V., Johanet C., Soulie E., Abuaf N. Development of an immunoenzyme assay technique of ELISA type for detecting anti-SSB antibodies: Comparative study of 2 kits. Rev. Med. Interne. 14:1993;288-293.
20. Arroyave C. M., Mark A. S., Ainis H. Identification of antinuclear, nucleolar,and SS-A antibodies using an immunassay system. Rev. Alerg. Mex. 41:1994;46-50.
21. Alem M., Moghadam S., Malki J., Zaidi A., Nayak N., Li T. M. Detection of autoantibodies to nuclear antigens by EIA and IF techniques. Allerg. Immunol.(Paris). 29:1997;188.
22. Iwata H., Aotsuka S., Okawa M., Kinoshita M., Sumiya M. Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens. Ryumachi. 37:1997;548-555.
23. Sanchez-Guerrero J., Lew R. A., Fossel A. H., Schur P. H. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum. 39:1996;1055-1061.
24. Veldhoven C. H., Heilof J. F., Huisman J. G., Smeenk R. J. The development of a quantitative assay for the detection of anti-Ro/SS-A and anti-La/SS-b autoantibodies using purified recombinant proteins. J. Immunol. Methods. 151:1992;177-189.
25. Wagatsuma M., Asami N., Miyachi J., Uchida S., Watanabe H., Amann E. Antibody recognition of the recombinant human nuclear antigens RNP 70 kD, SS-A, SS-B, and Sm-D by autoimmune sera. Mol. Immunol. 30:1993;1491-1498.
26. Delpech A., Gilbert D., Daliphard S., Le Loet X., Godin M., Tron F. Antibodies to Sm, RNP, and SSB detected by solid-phase ELISAs using recombinant antigens: a comparsion study with counter immunelectrophoresis and immunoblotting. J. Clin. Lab. Anal. 7:1993;197-202.
27. McCauliffe D. P., Yin H., Wang L., Lucas L. Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa R0(SSA) proteins. J. Rheumatol. 21:1994;1073-1080.
28. Garcia-Lerma J. G., Mendoza A. Z., Ramos M. J., Sequi J. Evaluation of recombinant Ro/SSA, La/SSB, Sm, and U1 RNP autoantigens in clinical diagnosis. J. Clin. Lab. Anal. 9:1995;52-58.
29. Yamanaka K., Takasaki Y. Enzyme-immunoassay for autoantibodies using recombinant antigens. Nippon Rinsho. 53:1995;2283-2289.
30. Ou Y., Sun D., Sharp G. C., Hoch S. O. Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system. Clin. Immunol. Immunpathol. 83:1997;310-317.
31. Miyawaka S. Clinical evaluation of quantitative measurement of various antinuclear antibodies by enzyme immunoassay. Rinsho Byori. 42:1994;467-475.
32. Takasaki Y. Enzyme-immunoassay using recombinant antigen. Rinsho Byori. 41:1993;841-850.
33. Yamanaka K., Takasaki Y. Enzyme-immunoassay for autoantibodies using recombinant antigens. Nippon Rinsho. 53:1995;2283-2289.
34. Elkon K. B., Jankowski P. W. Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP, and Jo-1 proteins defined by two-dimensional gel electrophoresis and immunoblotting. J. Immunol. 134:1985;3819-3824.
35. Costa O., Monier J. C. Antihistone antibodies detectd by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis. J. Rheum. 13:1986;722-725.
36. Chan E. K., Pollard K. M. Autoantibodies to ribonucleoprotein particles by immunoblotting. Manual of Clinical Laboratory Immunology. 1992;Am. Soc. Microbiol. Washington. p. 755-671.
37. Earnshawe W., Bordwell B., Marino C., Rothfield N. Three human chromosomal autoantigens are recognized by sera from patients with anticentromere antibodies. J. Clin. Invest. 77:1986;426-430.
38. Wollersheim H., Thien T., Hoet M. H., Van Venrooy W. J. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon. Eur. J. Clin. Invest. 19:1989;535-541.
39. Westgeest A. A., van den Brink H. G., de Jong J., Swaak A. J., Smeenk R. J. Routine testing for antinuclear antibodies: A comparison of immunofluorescence, counterimmunoelectrophoresis, and immunoblotting. J. Autoimmun. 1:1988;159-170.
40. Seelig H. P. S. Other autoantibodies to nuclear antigens. Peter J. B., Schoenfeld Y. Autoantibodies. 1996;582-594 Elsevier, New York.
41. Haynes D. C., Kite K., O'Connor L. The detection of antigen specific antinuclear antibodies: Evaluation of a membrane-based enzyme immunoassay. Euro. Clin. Lab. Dec. 1989.
42. Paxton H., Bendele T., O'Connor L., Haynes D. C. Evaluation of the RheumaStrip ANA profile test: A rapid test strip procedure for simultaneously determining antibodies to autoantigens U1-Ribonucleoprotein (U1-RNP), SM, SS-A/Ro, SS-B/La, and to native DNA. Clin. Chem. 36:1990;792-797.
43. Vaccia D., Cataldi V., Morozzi G., Bacarelli M. R., Ciali A., Pucci G., Marcolongo R. Anti-ENA antibody determination in various connective tissue diseases: Comparison of 2 detection techniques. Boll. Soc. Ital. Biol. Sper. 69:1993;45-48.
44. Uyttenbroeck W., Cooreman W., Scharpe S. The presence of antibodies against extractable nuclear antigens in serum: A comparison of immunoblotting versus radial immunodiffusion. Ann. Clin. Biochem. 30:1993;83-86.
45. Ermens A. A. M., Bauens J. M., van Gemert A. C. M., van Duijnhoven J. L. P. Simple dot-blot method evaluated for detection of antibodies against extractable nuclear antigens. Clin. Chem. 42:1997;2420-2422.
46. Manoussakis M. N., Kistis K. G., Liu X., Aidinis V., Guialis A., Moutsopoulos H. M. Detection of anti-Ro(SA) antibodies in autoimmune diseases: Comparison of five methods. Br. J. Rheum. 32:1993;449-455.
47. Cretien P., Soulie E., Johanet C., Abuaf N. Comparisons of double immunodiffusion, ELISA, western blot and CAPE blot for the detection of anti-SSA antibody: Study of anti-SSA prevalence in systemic lupus erythematosus. J. Autoimmun. 7:1994;379-388.
48. Akashi Y., Tokuda M., Kurata N., Yoshizawa N., Takahara J. Detection of anti-small nuclear ribonucleoprotein antibody in patients with collagen disease- a comparison of sensitivities of four methods. Ryumachi. 35:1995;552-558.
49. Grigolo B., Mazzetti I., Borzi R. M., Meliconi R., Origgi L., Scorza R., Facchini A. Comparison of different methods for the detection of autoantibodies in autoimune diseases. Int. J. Clin. Lab Res. 25:1995;205-210.
50. Bridges A. J., Lorden T. E., Havighurst T. C. Autoantibody testing for connective tissue diseases: Comparison of immunodiffusion, immunoblot, and enzyme immunoassay. Am. J. Clin. Pathol. 108:1997;406-410.
51. Barakat S., Meyer O., Torterotot F., Youinou P., Briand J. P., Kahn M. F., Muller S. IgG antibodies from patients with primary Sjogren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-dD SSA/Ro protein. Clin. Exp. Immunol. 89:1992;38-45.
52. Ricchiuti V., Briand J. P., Meyer O., Isenberg D. A., Pruijn G., Muller S. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin. Exp. Immunol. 95:1994;397-407.
53. Hecht B., Siegel N., Adler M. Prognostic indices in lupus neptritis. Medicine. 56:1976;163.
54. Monestier M. Nucleolar autoantibodies. Peter J. B., Schoenfeld Y. Autoantobodies. 1996;567-573 Elsevier, New York.
55. Peter J. B., Schoenfeld Y. Autoantibodies. 1996;Elsevier, New York.
56. Lerner M. R., Boyle J. A., Hardin J. A., Steitz J. A. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science. 211:1981;400-402.
57. Gottlieb E., Steitz J. A. Function of mammalian LA protein: Evidence for its action in transcription termination by RNA polymerase III. EMBO J. 8:1989;851-861.
58. Jaskowski T. D., Schroder C., Martins T. B., Mouritsen L., Hill H. R. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens. J. Clin. Lab. Anal. 9:1995;166-172.
59. Asanuma H., Miyake J., Miyawaki S. Newer approach of screening test for antinuclear antibodies: An enzyme-linked immunosorbent assay detecting antinuclear antibodies characteristic of connective tissue diseases. Nihon Rinsho Meneki Gakkai Kaishi. 20:1997;417-427.
60. Froelich C. J., Wallman J., Skosey J. L., Teoodorescu M. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB). J. Rheumatol. 17:1990;192-200.
61. Jaskowski T. D. Screening for antinuclear antibodies by enzyme immunoassay. Am. J. Clin. Pathol. 105:1996;468-473.
62. Shiba N., Note R., Hayashi S., Ozawa T., Niiya K., Sakuragawa N. A comparative study of the ELISA and IF methods for antinuclear antibody test. Rinsho Byori. 45:1997;175-178.
63. Gniewek R. A., Stites D. P., McHugh T. M., Hilton J. F., Nakagawa M. Comparison of antinuclear antibody testing methods: Immunofluorescence assay versus enzyme immunoassay. Clin. Diag. Lab. Immunol. 4:1997;185-188.
64. Gniewed R. A., Sandbulte C., Fox P. C. Comparison of antinuclear antibody testing methods by ROC analysis with reference to disease diagnosis. Clin. Chem. 43:1997;1987-1989.
65. Carey J. L. Enzyme immunoassays for antinuclear antibodies. Clin. Lab. Med. 17:1997;355-365.
66. Monce N. M., Bogusky R. T., Cappell N. N. An enzyme immunoassay screening test for the detection of total antinuclear antibodies. J. Clin. Lab. Anal. 1991;439-442.
67. Kurki P., Gripenberg M., Partanen P., Helve T. Screening test for rheumatic diseases: A combined enzyme immunoassay of rheumatoid factors and antibodies to DNA and extractable nuclear antigens. J. Clin. Pathol. 40:1987;1475-1480.
68. Emlen W., O'Neill L. Clinical significance of antinuclear antibodies: Comparison of detection with immunofluorescence and enzyme-linded immunosorbent assays. Arthritis Rheum. 40:1997;1612-1618.
69. Tan E. M. Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP and SS-B/La. Arthritis Rheum. 25:1982;1003-1005.
70. Smolen J. S. Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and Western blotting. Arthritis Rheum. 40:1997;413-418.